For the latest ecancer COVID-19 resources, click on this link

Breast

Prostate & urology

Lung & pleura

Colorectal & gastro

Melanoma & skin

Head & neck

Ovary & gynaecology

+ -

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

WCLC 2020

28 - 31 Jan 2021

Virtual, -, Singapore

WCLC 2020: Asian-relevant lung cancer research presented at Global Lung Cancer Conference hosted in Singapore

WCLC 2020: Asian-relevant lung cancer research presented at Global Lung Cancer Conference hosted in ...

WCLC 2020: TALENT study supports NLCST and NELSON trial results

WCLC 2020: TALENT study supports NLCST and NELSON trial results

WCLC 2020: Selected gene mRNA expression is not predictive of improved overall survival

WCLC 2020: Selected gene mRNA expression is not predictive of improved overall survival

WCLC 2020: Two ADAURA analyses support use of osimertinib for patients with surgically resected, stage IB to IIIA non-small cell lung cancer

WCLC 2020: Two ADAURA analyses support use of osimertinib for patients with surgically resected, sta...

WCLC 2020: Host immune classifier HIC assays may predict treatment response

WCLC 2020: Host immune classifier HIC assays may predict treatment response

WCLC 2020: Patient-reported outcomes from the randomised phase III CROWN study of first-line lorlatinib vs crizotinib in ALK positive NSCLC

WCLC 2020: Patient-reported outcomes from the randomised phase III CROWN study of first-line lorlati...

WCLC 2020: Patient-reported outcomes from the randomised phase III CROWN study of first-line lorlatinib versus in ALK NSCLC

WCLC 2020: Patient-reported outcomes from the randomised phase III CROWN study of first-line lorlati...

WCLC 2020: LCMC3: Neoadjuvant atezolizumab safe, meets primary endpoint of pathologic response rate

WCLC 2020: LCMC3: Neoadjuvant atezolizumab safe, meets primary endpoint of pathologic response rate

WCLC 2020: Nivolumab effective treatment for malignant mesothelioma

WCLC 2020: Nivolumab effective treatment for malignant mesothelioma

WCLC 2020: TALENT study supports NLCST and NELSON trial results

WCLC 2020: TALENT study supports NLCST and NELSON trial results

WLCL 2020: Disparities highlighted among key groups

WLCL 2020: Disparities highlighted among key groups

WCLC 2020: Study shows safety of adaptive RT in NSCLC patients

WCLC 2020: Study shows safety of adaptive RT in NSCLC patients

WCLC 2020: Lung-MAP translational discoveries shared at 2020 World Conference on Lung Cancer

WCLC 2020: Lung-MAP translational discoveries shared at 2020 World Conference on Lung Cancer

WCLC 2020: Sotorasib provides durable clinical benefit for patients with NSCLC and KRAS mutations

WCLC 2020: Sotorasib provides durable clinical benefit for patients with NSCLC and KRAS mutations

More from ecancer